Find clinical trials for Prostate Cancer in Salt Lake City, UT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Salt Lake City, UT, USA:
This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...
Phase 3
Murray, Utah, United States and 107 other locations
Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 53 other locations
recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD) and preliminary antitumor activity of ORIC-944 in patients with metastatic prostate...
Phase 1
Salt Lake City, Utah, United States and 5 other locations
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Salt Lake City, Utah, United States and 105 other locations
This study evaluates the diagnostic performance and safety of [18F]PSMA-1007 PET/CT imaging in patients with suspected recurrence of prostate...
Phase 3
Salt Lake City, Utah, United States and 5 other locations
prednisone/prednisolone compared with placebo plus abiraterone and prednisone/prednisolone in participants with metastatic castrate-resistant prostate...
Phase 3
Salt Lake City, Utah, United States and 183 other locations
This is an open-label, phase II umbrella trial assessing the anti-tumor activity of enfortumab alone and in combination with other anti-cancer...
Phase 2
Salt Lake City, Utah, United States
This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate ca...
Phase 2
Salt Lake City, Utah, United States and 17 other locations
hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with on ...
Phase 3
Salt Lake City, Utah, United States and 272 other locations
be prolonged in participants with metastatic castration-resistant prostate cancer (MCRPC) who receive lorigerlimab in addition to t...
Phase 2
West Valley City, Utah, United States of America and 50 other locations
Clinical trials
Research sites
Resources
Legal